Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors
- PMID: 2078273
Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors
Abstract
Serotonin (5-hydroxytryptamine [5-HT]) receptors can be classified either pharmacologically, into 5-HT1, 5-HT2, 5-HT3 and 5-HT4 receptors, or functionally, into G-protein-coupled receptors (5-HT1, 5-HT2, and 5-HT4) and ligand-gated ion channels (5-HT3). This article concentrates on the pharmacology, distribution, receptor-effector coupling, possible subtypes, and species differences of 5-HT3 receptors, which are equivalent to Gaddum and Picarelli's 5-HT-M receptor. Also presented here are some of the prominent features of the recently characterized 5-HT4 receptor. Although pharmacologic similarities have been suggested between 5-HT-M and 5-HT4 receptors (some potent 5-HT3 antagonists are active, with lower potency, at 5-HT4 receptors), it is clear that 5-HT4 receptors are different from 5-HT-M receptors.
Similar articles
-
5-Hydroxytryptamine-receptor subtypes.Clin Physiol Biochem. 1990;8 Suppl 3:19-27. Clin Physiol Biochem. 1990. PMID: 2132174 Review.
-
Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.J Psychiatry Neurosci. 1995 May;20(3):215-25. J Psychiatry Neurosci. 1995. PMID: 7786883 Free PMC article. Review.
-
Cardiovascular effects of serotonin agonists and antagonists.J Cardiovasc Pharmacol. 1990;15 Suppl 7:S17-34. J Cardiovasc Pharmacol. 1990. PMID: 1702484 Review.
-
[Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].Rev Neurol (Paris). 1994;150(1):3-15. Rev Neurol (Paris). 1994. PMID: 7801037 Review. French.
-
5-hydroxytryptamine: considerations about discovery, receptor classification and relevance to medical research.Arch Med Res. 1995 Winter;26(4):331-44. Arch Med Res. 1995. PMID: 8555727 Review.
Cited by
-
Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: involvement of 5-HT3 receptors.Naunyn Schmiedebergs Arch Pharmacol. 1991 Aug;344(2):143-9. doi: 10.1007/BF00167211. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1719432
-
5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.Br J Pharmacol. 1995 Jan;114(2):269-74. doi: 10.1111/j.1476-5381.1995.tb13222.x. Br J Pharmacol. 1995. PMID: 7881726 Free PMC article.
-
Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission.J Neurosci. 1998 Jul 1;18(13):4854-60. doi: 10.1523/JNEUROSCI.18-13-04854.1998. J Neurosci. 1998. PMID: 9634551 Free PMC article.
-
Current and prospective pharmacological targets in relation to antimigraine action.Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):371-94. doi: 10.1007/s00210-008-0322-7. Epub 2008 Jul 15. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18626630 Review.
-
"5-HT1R" or 5-HT1D sites? Evidence for 5-HT1D binding sites in rabbit brain.Naunyn Schmiedebergs Arch Pharmacol. 1992 Sep;346(3):249-54. doi: 10.1007/BF00173536. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1407010
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources